Most doctors in China accept bribe from pharma companies: Xinhua

The GlaxoSmithKline controversy opened the doors of investigation about the misconduct happening in the pharmaceutical industry.

Read Full Article

China's Commerce Ministry confident probe on drugmaker GlaxoSmithKline won't mar investor confidence

China remains confident that the ongoing investigations for alleged bribery of GSK execs in its China division won't mar investor confidence.

Read Full Article

GSK suspends plan to raise stake in GSK Consumer Nigeria

GlaxoSmithKline's plans to raise stakes in GSK Consumer Nigeria on hold after shareholder opposition.

Read Full Article

GSK's 20% China growth sales in focus as police alleges bribes and sexual favors

GlaxoSmithKline Plc's 20% increase in sales was currently in focus due to Public Security Ministry's accusations on bribery and sexual favors.

Read Full Article

AG Barr in talks with Blackstone and Lion Capital

Sources revealed that AG Barr could be buying GlaxoSmithKline's Ribena and Lucozade brands.

Read Full Article

Blackstone, Lion Capital to bid for Lucozade, Ribena

GSK was offered a formal takeover bid priced more than a billion pounds for its soft drink brand Lucozade and Ribena by Blackstone and Lion Capital.

Read Full Article

Deals of the day -- mergers and acquisitions

Bids, mergers, acquisitions and disposals involving European, U.S. and Asian companies.

Read Full Article
1 2

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics